WFG Advisors’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $21K | Hold |
450
| – | – | ﹤0.01% | 948 |
|
|
2017
Q1 | $19K | Hold |
450
| – | – | 0.01% | 898 |
|
|
2016
Q4 | $17K | Hold |
450
| – | – | ﹤0.01% | 974 |
|
|
2016
Q3 | $19K | Sell |
450
-75
| -14% | -$3.17K | ﹤0.01% | 958 |
|
|
2016
Q2 | $19K | Hold |
525
| – | – | 0.01% | 930 |
|
|
2016
Q1 | $20K | Hold |
525
| – | – | 0.01% | 894 |
|
|
2015
Q4 | $27K | Sell |
525
-189
| -26% | -$9.72K | 0.01% | 824 |
|
|
2015
Q3 | $33K | Hold |
714
| – | – | 0.01% | 762 |
|
|
2015
Q2 | $42K | Hold |
714
| – | – | 0.01% | 775 |
|
|
2015
Q1 | $39K | Sell |
714
-221
| -24% | -$12.1K | 0.01% | 797 |
|
|
2014
Q4 | $47K | Buy |
935
+10
| +1% | +$503 | 0.01% | 909 |
|
|
2014
Q3 | $43K | Sell |
925
-1,675
| -64% | -$77.9K | 0.01% | 984 |
|
|
2014
Q2 | $114K | Sell |
2,600
-28,997
| -92% | -$1.27M | 0.02% | 613 |
|
|
2014
Q1 | $1.32M | Buy |
31,597
+335
| +1% | +$13.9K | 0.26% | 78 |
|
|
2013
Q4 | $1.16M | Buy |
31,262
+4,864
| +18% | +$180K | 0.16% | 146 |
|
|
2013
Q3 | $926K | Buy |
26,398
+25,148
| +2,012% | +$882K | 0.14% | 168 |
|
|
2013
Q2 | $36K | Buy |
+1,250
| New | +$36K | 0.01% | 1011 |
|